Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
Nitrous Oxide, USP is an inhalational gas approved as a pharmaceutical product by Advanced Solutions Life Sciences. It is a well-established anesthetic and analgesic agent used across multiple medical settings. The mechanism involves rapid CNS depression through modulation of multiple neurotransmitter systems.
Product is at peak commercial stage with moderate competitive pressure (30%); team size appears limited given only 1 linked job opening.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department
Nitrous Oxide Versus Intravenous Sedation for Anesthesia
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
Worked on NITROUS OXIDE, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Advanced Solutions Life Sciences is hiring 1 role related to this product
Working on Nitrous Oxide, USP offers limited career growth opportunities given the mature, commodity nature of the product and minimal linked job openings. Roles are concentrated in IT and technical testing, not core commercial or medical affairs functions.
1 open roles linked to this drug